Literature DB >> 17882612

Does social class predict substance problems in young adults with ADHD?

Michael C Monuteaux1, Timothy E Wilens, Joseph Biederman.   

Abstract

The relationship between social class and substance use problems is unclear. We aimed to clarify this association in a sample of young adult males with and without attention-deficit/hyperactivity disorder (ADHD). We included 69 ADHD and 78 control subjects. Substance use problems were measured with the Drug Use Screening Inventory-Revised (DUSI). Among ADHD subjects, we found a U-shaped association, with elevated risk for substance-related problems at both ends of the SES spectrum. No significant association was found in controls. These findings indicate that substance use risk in ADHD subjects is especially vulnerable to social class.

Entities:  

Mesh:

Year:  2007        PMID: 17882612     DOI: 10.1080/10550490701525590

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  4 in total

1.  Childhood ADHD symptoms are associated with lifetime and current illicit substance-use disorders and in-site health risk behaviors in a representative sample of Latino prison inmates.

Authors:  Rafael A González; María C Vélez-Pastrana; José J Ruiz Varcárcel; Frances R Levin; Carmen E Albizu-García
Journal:  J Atten Disord       Date:  2012-12-04       Impact factor: 3.256

2.  Cigarette smoking associated with attention deficit hyperactivity disorder.

Authors:  Timothy E Wilens; Michael Vitulano; Himanshu Upadhyaya; Joel Adamson; Robert Sawtelle; Linsey Utzinger; Joseph Biederman
Journal:  J Pediatr       Date:  2008-06-05       Impact factor: 4.406

3.  Risk Factors for Substance Use Among Youth Experiencing Homelessness.

Authors:  Marguerita Lightfoot; Nancy Wu; Shana Hughes; Kate Desmond; Heather Tevendale; Robin Stevens
Journal:  J Child Adolesc Subst Abuse       Date:  2018-09-28

4.  A systematic review of global publication trends regarding long-term outcomes of ADHD.

Authors:  Paul Hodgkins; L Eugene Arnold; Monica Shaw; Hervé Caci; Jennifer Kahle; Alisa G Woods; Susan Young
Journal:  Front Psychiatry       Date:  2012-01-18       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.